Luminex and Antibody Detection in Kidney Transplantation

Overview

Journal Clin Exp Nephrol

Publisher Springer

Specialty Nephrology

Date 2012 May 4

PMID 22552384

Citations 10

Authors

Antonietta Picascia

Teresa Infante

Claudio Napoli

Affiliations

Soon will be listed here.

Abstract

Preformed anti-human leukocyte antigen (HLA) antibodies have a negative effect on kidney transplantation outcome with an increased rejection rate and reduction in survival. Posttransplantation production of donor-specific anti-HLA antibodies is indicative of an active immune response and risk of transplantation rejection. For many years the primary technique for anti-HLA antibody detection was complement-dependent cytotoxicity (CDC), which has been integrated by solid-phase assays as HLA antigen-coated bead methods (Luminex). This new technological approach has allowed identification of anti-HLA antibodies, not detectable using conventional CDC method, in patients awaiting kidney transplantation. Moreover, use of Luminex technology has enabled better definition of acceptable or unacceptable antigens favoring transplantation in highly immunized patients. However, there are still many unresolved issues, including the clinical relevance of antibodies detected with this system.

Citing Articles

Immunoassays and Mass Spectrometry for Determination of Protein Concentrations in Genetically Modified Crops.

Wang Y, Bednarcik M, Ament C, Cheever M, Cummings S, Geng T J Agric Food Chem. 2024; .

PMID: 38607999 PMC: 11046482. DOI: 10.1021/acs.jafc.3c09188.

Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection.

Asano Y, Daccache J, Jain D, Ko K, Kinloch A, Veselits M Nat Commun. 2021; 12(1):4372.

PMID: 34272370 PMC: 8285506. DOI: 10.1038/s41467-021-24615-6.

Specific amino acid patterns define split specificities of HLA-B15 antigens enabling conversion from DNA-based typing to serological equivalents.

Duygu B, Matern B, Wieten L, Voorter C, Tilanus M Immunogenetics. 2020; 72(6-7):339-346.

PMID: 32561995 PMC: 7456404. DOI: 10.1007/s00251-020-01172-8.

Effect of Preformed or De Novo Anti-HLA Antibodies on Function and Graft Survival in Kidney Transplant Recipients.

de Sousa M, Goncalez A, de Lima Zollner R, Mazzali M Ann Transplant. 2018; 23:457-466.

PMID: 29976918 PMC: 6248052. DOI: 10.12659/AOT.908491.

Outcome after Desensitization in HLA or ABO-Incompatible Kidney Transplant Recipients: A Single Center Experience.

Kauke T, Klimaschewski S, Schoenermarck U, Fischereder M, Dick A, Guba M PLoS One. 2016; 11(1):e0146075.

PMID: 26730981 PMC: 4711576. DOI: 10.1371/journal.pone.0146075.

References

Tait B . Solid phase assays for HLA antibody detection in clinical transplantation. Curr Opin Immunol. 2009; 21(5):573-7. DOI: 10.1016/j.coi.2009.07.017. View

Lachmann N, Terasaki P, Budde K, Liefeldt L, Kahl A, Reinke P . Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation. 2009; 87(10):1505-13. DOI: 10.1097/TP.0b013e3181a44206. View

Zachary A, Montgomery R, Leffell M . Defining unacceptable HLA antigens. Curr Opin Organ Transplant. 2008; 13(4):405-10. DOI: 10.1097/MOT.0b013e3283071450. View

Kaneku H . Impact of donor-specific HLA antibodies in transplantation, a review of the literature published in the last three years. Clin Transpl. 2011; :283-306. View

Zachary A, Klingman L, Thorne N, Smerglia A, Teresi G . Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation. 1995; 60(5):498-503. DOI: 10.1097/00007890-199509000-00016. View

Opelz G, Claas F . Which human leukocyte antigen antibodies are really clinically relevant?. Hum Immunol. 2009; 70(8):561-2. DOI: 10.1016/j.humimm.2009.06.019. View

Narayan S, Tsai E, Zhang Q, Wallace W, Reed E, Ettenger R . Acute rejection associated with donor-specific anti-MICA antibody in a highly sensitized pediatric renal transplant recipient. Pediatr Transplant. 2011; 15(1):E1-7. PMC: 3878296. DOI: 10.1111/j.1399-3046.2010.01407.x. View

El-Awar N, Lee J, Terasaki P . HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol. 2005; 66(9):989-97. DOI: 10.1016/j.humimm.2005.07.005. View

Pereira S, Perkins S, Lee J, Shumway W, LeFor W, Lopez-Cepero M . Donor-specific antibody against denatured HLA-A1: clinically nonsignificant?. Hum Immunol. 2011; 72(6):492-8. DOI: 10.1016/j.humimm.2011.02.012. View

10.

Bartel G, Wahrmann M, Exner M, Regele H, Huttary N, Schillinger M . In vitro detection of C4d-fixing HLA alloantibodies: associations with capillary C4d deposition in kidney allografts. Am J Transplant. 2007; 8(1):41-9. DOI: 10.1111/j.1600-6143.2007.01998.x. View

11.

van den Berg-Loonen E, Billen E, Voorter C, van Heurn L, Claas F, van Hooff J . Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation. 2008; 85(8):1086-90. DOI: 10.1097/TP.0b013e31816b3ed1. View

12.

Duquesnoy R, Marrari M . Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. Transpl Immunol. 2010; 24(3):164-71. DOI: 10.1016/j.trim.2010.12.003. View

13.

Monien S, Salama A, Schonemann C . ELISA methods detect HLA antibodies with variable sensitivity. Int J Immunogenet. 2006; 33(3):163-6. DOI: 10.1111/j.1744-313X.2006.00586.x. View

14.

Gloor J . The utility of comprehensive assessment of donor specific anti-HLA antibodies in the clinical management of pediatric kidney transplant recipients. Pediatr Transplant. 2011; 15(6):557-63. DOI: 10.1111/j.1399-3046.2010.01455.x. View

15.

Terasaki P . Humoral theory of transplantation. Am J Transplant. 2003; 3(6):665-73. DOI: 10.1034/j.1600-6143.2003.00135.x. View

16.

Patel R, Terasaki P . Significance of the positive crossmatch test in kidney transplantation. N Engl J Med. 1969; 280(14):735-9. DOI: 10.1056/NEJM196904032801401. View

17.

Colombo M, Haworth S, Poli F, Nocco A, Puglisi G, Innocente A . Luminex technology for anti-HLA antibody screening: evaluation of performance and of impact on laboratory routine. Cytometry B Clin Cytom. 2007; 72(6):465-71. DOI: 10.1002/cyto.b.20353. View

18.

Proust B, Kennel A, Ladriere M, Kessler M, Perrier P . Unexpected anti-HLA-DR and -DQ alloantibodies after nephrectomy of an HLA-DR and -DQ identical first renal transplant. Transpl Immunol. 2009; 21(3):166-8. DOI: 10.1016/j.trim.2009.03.003. View

19.

Bryan C, Luger A, Smith J, Warady B, Wakefield M, Schadde E . Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. Clin Transplant. 2009; 24(1):56-61. DOI: 10.1111/j.1399-0012.2009.01167.x. View

20.

Chen G, Sequeira F, Tyan D . Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol. 2011; 72(10):849-58. DOI: 10.1016/j.humimm.2011.07.001. View